The Biology of Estrogen Receptor Negative Breast Cancer in Various Racial and Ethnic Groups U01 Federal Grant

Home

RESEARCH

ARTICLES

RESOURCES

Government Jobs
Grant Forums

FAST GRANT SEARCH

FEDERAL GRANTS NEWSLETTER

The Biology of Estrogen Receptor-Negative Breast Cancer in Various Racial and Ethnic Groups (U01)

The summary for the The Biology of Estrogen Receptor-Negative Breast Cancer in Various Racial and Ethnic Groups (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.

Federal Grant Title:	THE BIOLOGY OF ESTROGEN RECEPTOR-NEGATIVE BREAST CANCER IN VARIOUS RACIAL AND ETHNIC GROUPS (U01)
Federal Agency Name:	National Institutes of Health
Program Name:	Cancer Biology Research
Grant Categories:	Education Health
CFDA Number:	93.396
Funding Opportunity Number:	RFA-CA-09-026
Posted Date:	Aug 13, 2009
Creation Date:	Aug 13, 2009
Original Application Deadline:	Jan 05, 2010
Current Application Deadline:	Jan 05, 2010
Archive Date:	Feb 05, 2010
Total Program Funding:	$2,000,000
Maximum Federal Grant Award:	$667,000
Minimum Federal Grant Award:	Information not provided
Expected Number of Awards:	Information not provided
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Regional Organizations; U.S. Territory or Possession.
Grant Description: Purpose.The purpose of this funding opportunity announcement (FOA) is to promote the systematic study of the biology of estrogen receptor (ER)-negative human breast cancers, the characterization of their molecular features, the signaling pathways and networks that support their growth, as well as to identify differences in the biology of ER-negative breast tumors among racial and ethnic groups. The information will be crucial in developing early detection and intervention strategies. This initiative will support studies on: the basic biology of ER-negative breast cancers and delineation of differences that exist between ER-positive and ER-negative breast cancers; the identification of the subtypes or heterogeneity that exist within ER-negative breast cancers; and the determination of whether the biology of ER-negative breast tumors differs across racial and ethnic groups. In order to address these goals, the National Cancer Institute (NCI) solicits applications from collaborative teams of interdisciplinary investigators focused on characterizing the biologic drivers, including genetic, epigenetic, molecular, and cellular factors, of ER-negative human breast cancer development and progression. Mechanism of Support. This FOA will utilize the NIH U01 cooperative agreement mechanism. Funds Available and Anticipated Number of Awards. The NCI expects to commit approximately $10 million for 5 years to fund up to three awards.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-ca-09-026.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Collaborative Research in Integrative Cancer Biology (U01); • Revisions for Early-Stage Development of Informatics Technology (P01); • Revisions for Early-Stage Development of Informatics Technology (U01); • Revisions for Early-Stage Development of Informatics Technology (R01); • Early-Stage Development of Informatics Technology (U01); • Mouse Models of Human Cancers Consortium; • Integrative Cancer Biology Programs; • Memory T Lymphocytes in Cancer Immunology (R21)
More Grants from the National Institutes of Health: • NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01); • Biophysical and Biomechanical Aspects of Embryonic Development (R01); • Biophysical and Biomechanical Aspects of Embryonic Development (R21); • Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agricultural...; • MARC Undergraduate Student Training in Academic Research (U-STAR) National Research Servic...